Skip to content

Clinical trials

Phase 3 Graft vs Host Disease trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Graft vs Host Disease Phase: Phase 3 Country / region: United States Clear all

34 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20012
20023
20041
20061
20072
20083
20092
20103
20111
20161
20174
20181
20191
20201
20221
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed24
Terminated6
Withdrawn2
Recruiting1
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Incyte Corporation3
Children's Oncology Group2
Dana-Farber Cancer Institute2
Fred Hutchinson Cancer Center2
Mesoblast, Inc.2
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins2
Adienne SA1
Baxalta now part of Shire1
CSL Behring1
Colorado Blood Cancer Institute1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Graft vs Host Disease34
Precursor Cell Lymphoblastic Leukemia-Lymphoma13
Leukemia, Myeloid, Acute8
Lymphoma, Non-Hodgkin8
Hodgkin Disease7
Leukemia7
Leukemia, Lymphocytic, Chronic, B-Cell7
Lymphoma7
Myelodysplastic Syndromes7
Burkitt Lymphoma6

Trials

Showing 1 to 25 of 34. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.